State of Wyoming’s Taysha Gene Therapies TSHA Stock Holding History

State of Wyoming’s Portfolio TSHA Stock Details TSHA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,797	Closed	-$4.03K	–	1899
2024 Q2	$4.03K	Buy	+1,797	New	+$5.23K	﹤0.01%	1602

Other funds holding TSHA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

State of Wyoming's TSHA Position: Q3 2024 in Review

State of Wyoming sold out of Taysha Gene Therapies (TSHA) in Q3 2024, closing a stake of 1,797 shares — an estimated $4.03K sold.

State of Wyoming first reported a position in TSHA in Q2 2024 and held it in 1 quarter. The position peaked at $4.03K in Q2 2024. 119 funds tracked by Wall St. Rank hold TSHA as of Q3 2024.

State of Wyoming reported no remaining Taysha Gene Therapies position as of Q3 2024 after selling out during the quarter.
State of Wyoming sold 1,797 Taysha Gene Therapies shares in Q3 2024, an estimated $4.03K.
State of Wyoming first reported a position in Taysha Gene Therapies in Q2 2024 and held it in 1 quarter.
State of Wyoming's Taysha Gene Therapies position peaked at $4.03K in Q2 2024.
119 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q3 2024.

Based on State of Wyoming's 13F filing for Q3 2024, filed 14 Nov 2024.